Inhibition of human multidrug resistance P-glycoprotein 1 by analogues of a potent δ-opioid antagonist

Brain Research

Volumn 902, Issue 1, 2001, Pages 131-134

  Lovekamp, Tara ^a   Cooper, Peter S ^b   Hardison, Jenny ^a   Bryant, Sharon D ^a   Guerrini, Remo ^c   Balboni, Gianfranco ^c   Salvadori, Severo ^c   Lazarus, Lawrence H ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c UNIVERSITY OF FERRARA   (Italy)

Author keywords

Opioid receptor antagonists; Dmt Tic; hMDR1; Hydrophobicity; P Glycoprotein

Indexed keywords

2',6' DIMETHYL LEVO TYROSINE 1,2,3,4 TETRAHYDROISOQUINOLINE 3 CARBOXYLIC ACID; DELTA OPIATE RECEPTOR ANTAGONIST; DELTORPHIN; DERMORPHIN; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; GLYCOPROTEIN P; MU OPIATE RECEPTOR AGONIST; MU OPIATE RECEPTOR ANTAGONIST; NALOXONE; NALTREXONE; NALTRINDOLE; UNCLASSIFIED DRUG; VERAPAMIL;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; FIBROBLAST CULTURE; INHIBITION KINETICS; NONHUMAN; PHARMACOPHORE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

3T3 CELLS; ADAMANTANE; ANIMALS; CELL LINE; DIPEPTIDES; DRUG RESISTANCE, MULTIPLE; FIBROBLASTS; FLUORESCEINS; HUMANS; MICE; NARCOTIC ANTAGONISTS; OLIGOPEPTIDES; P-GLYCOPROTEIN; PEPTIDES, CYCLIC; RECEPTORS, OPIOID, DELTA; STRUCTURE-ACTIVITY RELATIONSHIP; TETRAHYDROISOQUINOLINES; TRANSFECTION; VERAPAMIL;

EID: 0035946985     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(01)02363-0     Document Type: Article

References (19)

1. Blood-brain barrier permeability and bioavailability of a highly potent and μ-selective opioid receptor antagonist. CTAP: Comparison with morphine
2. Opioid diketopiperazines: Synthesis and activity of a prototypic class of opioid antagonists
3. Opioid diketopiperazines: Refinement of the δ-opioid antagonist pharmacophore
4. Synthetic and natural opiates interact with P-glycoprotein in multidrug-resistant cells
5. Dmt-Tic-OH, a highly selective and potent δ-opioid dipeptide receptor antagonist after systemic administration in the mouse
6. Acid catalysis in the formation of dioxopiperazines from peptides containing tetrahydroisoquinoline-3-carboxylic acid at position 2
7. 2,5] enkephalin in mdr 1a-gene-deficient mice
8. 2,5]enkephalin by P-glycoprotein modulation
9. Blood-brain barrier restriction of peptides and the low uptake of enkephalins
10. Deltorphin transport across the blood-brain barrier
11. 3H]azidopine photolabeling of P-glycoprotein by newly synthesized dihyropyridine analogues in a human cell line
12. Circumvention of adriamycin resistance by dipyridamole analogues: A structure-activity relationship study
13. Evolution of the Dmt-Tic pharmacophore: N-terminal methylated derivatives with extraordinary δ-opioid antagonist activity
14. Further studies on the Dmt-Tic pharmacophore: Hydrophobic substituents at the C-terminus endows δ antagonists to manifest μ agonism or μ antagonism
15. P-Glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs
16. 2]deltorphin I and II analogues; in vitro blood-brain barrier permeability and stability
17. 2] Leu-enkephalin derivatives conjugated with the 1-adamantane moiety
18. 2,5] enkephalin, across the blood-brain and the blood-cerebrospinal fluid barriers
19. Physical-chemical properties shared by compounds that modulate multidrug resistance in human leukemic cells